Matzim LA 240mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely.
Take your medication as directed by your doctor, swallowing the tablets whole without chewing, breaking, or crushing them.
Establish a routine by taking your medication at the same time every day.
Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start feeling well.
Storing and Disposing of Your Medication
To maintain the effectiveness and safety of your medication:
Store it at room temperature, protected from light and moisture.
Keep it in a dry place, avoiding storage in a bathroom.
Keep all medications in a secure location, out of the reach of children and pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so by your pharmacist or healthcare provider. Check with your pharmacist for guidance on the best disposal method, and consider participating in local drug take-back programs.
What to Do If You Miss a Dose
If you miss a dose of your medication:
Take it as soon as you remember.
If it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule.
Do not take two doses at the same time or take extra doses to make up for the missed one.
Lifestyle & Tips
- Take the medication at the same time each day, preferably in the morning.
- Swallow the tablet whole; do not crush, chew, or divide extended-release tablets.
- Avoid grapefruit and grapefruit juice while taking this medication, as it can increase the drug's effects and side effects.
- Monitor your blood pressure and heart rate regularly as advised by your doctor.
- Avoid sudden changes in position (e.g., standing up quickly) to prevent dizziness or lightheadedness.
- Limit alcohol consumption, as it can increase the hypotensive effects.
- Maintain a healthy diet, regular exercise, and manage stress as part of a comprehensive treatment plan for hypertension or angina.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of liver problems, including:
+ Dark urine
+ Tiredness
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Severe dizziness or fainting
Slow heartbeat
New or worsening abnormal heartbeat
Worsening heart failure (if you have a history of heart failure, consult your doctor). Seek immediate medical attention if you experience:
+ Shortness of breath
+ Sudden weight gain
+ Swelling in the arms or legs
Severe skin reactions, including:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other severe skin reactions (sometimes life-threatening). Seek medical help right away if you notice:
+ Red, swollen, blistered, or peeling skin
+ Other skin irritation (with or without fever)
+ Red or irritated eyes
+ Sores in your mouth, throat, nose, or eyes
Other Possible Side Effects
As with any medication, you may experience side effects. While many people have no side effects or only mild ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:
Headache
* Feeling dizzy, tired, or weak
This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe dizziness or fainting
- Very slow heart rate (less than 50 beats per minute)
- New or worsening swelling in your ankles or feet
- Shortness of breath, especially with exertion or lying down
- Unusual tiredness or weakness
- Yellowing of the skin or eyes (jaundice)
- Dark urine or pale stools (signs of liver problems)
- Severe headache that is unusual for you
- Chest pain that worsens or does not go away
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
Certain types of abnormal heart rhythms, as this medication is not suitable for use with many types of irregular heartbeats. If you are unsure, consult your doctor or pharmacist for guidance.
Specific health conditions, including:
+ Fluid accumulation in the lungs
+ Low blood pressure
+ Recent heart attack
Concurrent use of certain medications, such as:
+ Ivabradine
+ Rifampin
This list is not exhaustive, and it is crucial to disclose all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems you are experiencing. Your doctor and pharmacist need this information to ensure safe use of this medication with your other treatments and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
When starting this medication, avoid driving and other activities that require alertness until you understand how it affects you. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying position, and be cautious when navigating stairs.
As directed by your doctor, regularly monitor your blood pressure and heart rate. You may need to undergo an electrocardiogram (ECG) before initiating this medication and during treatment. Discuss this with your doctor.
If you have high blood pressure and are taking this medication, consult your doctor before using over-the-counter (OTC) products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, and certain natural products or aids.
If you consume grapefruit juice or eat grapefruit regularly, discuss this with your doctor. Additionally, talk to your doctor before consuming alcohol while taking this medication.
If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.
If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor. You will need to discuss the potential benefits and risks of this medication to both you and your baby.
Overdose Information
Overdose Symptoms:
- Severe hypotension (very low blood pressure)
- Profound bradycardia (very slow heart rate)
- Heart block (abnormal heart rhythm)
- Cardiogenic shock (heart unable to pump enough blood)
- Asystole (cardiac arrest)
- Dizziness
- Fainting
- Confusion
What to Do:
Seek immediate medical attention. Call 911 or your local emergency number. For poison control, call 1-800-222-1222. Treatment may involve gastric lavage, activated charcoal, IV fluids, atropine, calcium gluconate, vasopressors, and/or glucagon, depending on severity.
Drug Interactions
Contraindicated Interactions
- Ivabradine (risk of severe bradycardia)
- Dantrolene (IV) (risk of cardiovascular collapse)
Major Interactions
- Beta-blockers (e.g., metoprolol, carvedilol) - increased risk of bradycardia, AV block, heart failure
- Digoxin - increased digoxin levels, risk of toxicity
- Amiodarone - increased risk of bradycardia, AV block, hypotension
- Statins (e.g., simvastatin, lovastatin) - increased statin levels, risk of myopathy/rhabdomyolysis
- Fentanyl (CYP3A4 substrate) - increased fentanyl levels, respiratory depression
- Immunosuppressants (e.g., cyclosporine, tacrolimus, sirolimus) - increased immunosuppressant levels, toxicity
- Alpha-blockers (e.g., prazosin, doxazosin) - increased risk of hypotension
- Other CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) - increased diltiazem levels
- Other CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin) - decreased diltiazem levels
Moderate Interactions
- Clonidine - additive bradycardia/hypotension
- Nitrates - additive hypotensive effects
- Theophylline - increased theophylline levels
- Buspirone - increased buspirone levels
- Midazolam/Triazolam - increased benzodiazepine levels
- Phenytoin - increased phenytoin levels
- Grapefruit juice - increased diltiazem levels
Minor Interactions
- Cimetidine - increased diltiazem levels (minor effect)
- Ranitidine - increased diltiazem levels (minor effect)
Monitoring
Baseline Monitoring
Rationale: To establish baseline and guide initial dosing for hypertension/angina.
Timing: Prior to initiation
Rationale: To establish baseline and assess for bradycardia risk.
Timing: Prior to initiation
Rationale: To assess for pre-existing conduction abnormalities (e.g., AV block) that may be exacerbated.
Timing: Prior to initiation, especially if cardiac history
Rationale: Diltiazem is extensively metabolized by the liver; to assess baseline hepatic function.
Timing: Prior to initiation
Rationale: To assess baseline renal function, though renal impairment has less impact on dosing.
Timing: Prior to initiation
Routine Monitoring
Frequency: Regularly (e.g., weekly initially, then monthly or as clinically indicated) until stable, then periodically.
Target: <130/80 mmHg (or individualized target)
Action Threshold: Persistent hypotension (<90/60 mmHg) or inadequate BP control.
Frequency: Regularly (e.g., weekly initially, then monthly or as clinically indicated) until stable, then periodically.
Target: 50-90 bpm (or individualized target)
Action Threshold: Persistent bradycardia (<50 bpm) or symptomatic bradycardia.
Frequency: Ongoing patient assessment.
Target: Reduction or elimination of angina episodes.
Action Threshold: Worsening or persistent angina.
Frequency: Regular patient assessment.
Target: Absence or minimal edema.
Action Threshold: Significant or worsening lower extremity edema.
Frequency: Periodically (e.g., every 6-12 months or as clinically indicated), especially if signs of hepatic dysfunction or on high doses.
Target: Within normal limits.
Action Threshold: Significant elevation of liver enzymes (e.g., >3x ULN).
Frequency: As clinically indicated (e.g., if new symptoms of bradycardia, dizziness, or with concomitant use of other AV nodal blocking agents).
Target: Normal sinus rhythm, PR interval <0.20 sec.
Action Threshold: Development of new or worsening AV block (e.g., 2nd or 3rd degree).
Symptom Monitoring
- Dizziness
- Lightheadedness
- Fatigue
- Headache
- Swelling in ankles/feet (edema)
- Shortness of breath
- Chest pain (worsening or new)
- Palpitations
- Yellowing of skin/eyes (jaundice)
- Dark urine
- Unusual tiredness (signs of liver dysfunction)
Special Patient Groups
Pregnancy
Category C. Diltiazem should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Animal studies have shown adverse effects, but there are no adequate and well-controlled studies in pregnant women.
Trimester-Specific Risks:
Lactation
Diltiazem is excreted in breast milk. The American Academy of Pediatrics considers diltiazem to be compatible with breastfeeding, but caution is advised. Monitor the infant for bradycardia, hypotension, and sedation.
Pediatric Use
Safety and effectiveness in pediatric patients have not been established for hypertension or angina. Use is generally not recommended. Limited off-label use for supraventricular tachycardia in critical care settings, typically IV.
Geriatric Use
Elderly patients may be more sensitive to the effects of diltiazem, particularly hypotensive and bradycardic effects. A lower starting dose and slower titration may be appropriate. Monitor closely for adverse effects.
Clinical Information
Clinical Pearls
- Extended-release diltiazem formulations are not interchangeable; ensure the patient receives the specific brand/formulation prescribed.
- Advise patients to take the medication consistently at the same time each day to maintain steady drug levels.
- Counsel patients on the importance of not crushing or chewing extended-release tablets to avoid dose dumping and potential adverse effects.
- Diltiazem is a potent CYP3A4 inhibitor; carefully review concomitant medications for potential drug-drug interactions, especially with statins, immunosuppressants, and other cardiovascular drugs.
- Monitor for signs of peripheral edema, a common side effect, and differentiate from signs of heart failure.
- Patients with pre-existing second- or third-degree AV block or sick sinus syndrome (without a pacemaker) should generally not receive diltiazem due to the risk of severe bradycardia or asystole.
Alternative Therapies
- Other non-dihydropyridine calcium channel blockers (e.g., verapamil)
- Dihydropyridine calcium channel blockers (e.g., amlodipine, nifedipine)
- Beta-blockers (e.g., metoprolol, atenolol)
- ACE inhibitors (e.g., lisinopril, enalapril)
- Angiotensin Receptor Blockers (ARBs) (e.g., losartan, valsartan)
- Thiazide diuretics (e.g., hydrochlorothiazide)
- Nitrates (for angina) (e.g., isosorbide mononitrate)
- Antiarrhythmics (e.g., amiodarone, flecainide for arrhythmias)